Zealand Pharma A/S (LON:0NZU)
428.94
+3.61 (0.85%)
At close: Sep 16, 2025
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 3.53 billion as of September 18, 2025. Its market cap has decreased by -50.31% in one year.
Market Cap
3.53B
Enterprise Value
1.65B
Revenue
1.05B
Ranking
n/a
PE Ratio
4.59
Stock Price
428.94
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 3.53B, an increase of 2,106.39%. That is a compound annual growth rate of 23.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 3.53B | -37.27% |
Dec 30, 2024 | 5.62B | 121.65% |
Dec 29, 2023 | 2.54B | 105.19% |
Dec 30, 2022 | 1.24B | 74.70% |
Dec 30, 2021 | 707.55M | -33.54% |
Dec 30, 2020 | 1.06B | 9.92% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 177.00B |
HSBC Holdings | 174.78B |
Shell | 153.13B |
Unilever | 114.20B |
Rolls-Royce Holdings | 96.19B |
British American Tobacco p.l.c. | 90.16B |
Rio Tinto Group | 79.05B |
BP p.l.c. | 64.73B |